Aparicio, Luis
Crowley, Laura
Christin, John R.
Laplaca, Caroline J.
Hibshoosh, Hanina
Rabadan, Raul
Shen, Michael M.
Article History
Received: 15 April 2024
Accepted: 8 January 2025
First Online: 17 January 2025
Declarations
:
: Animal studies were approved by and were performed according to ethical standards set by the Columbia University Irving Medical Center (CUIMC) Institutional Animal Care and Use Committee (IACUC), under protocol AABT5655. For human studies, patients provided written informed consent to participate in this study under protocol AAAN8850 approved by the Institutional Review Board at Columbia University Irving Medical Center. Prostate tissues were provided by the Tissue Bank of the Herbert Irving Comprehensive Cancer Center. This research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: R.R. is a founder of Genotwin and a member of the Scientific Advisory Board of Diatech Pharmacogenetics and Flahy. M.M.S. is a consultant for K36 Therapeutics. None of these activities is related to the work described in this manuscript. The other authors declare that they have no competing interests.